December 3, 2012—Rep. Jo Ann Emerson (R-Mo.), a leading advocate of expanding and improving the 340B drug discount program, announced that she will retire from Congress in February.
The 16-year veteran lawmaker is an original co-sponsor of the 340B Program Improvement Act (H.R. 2674), which in addition to extending 340B discounts to the hospital inpatient setting would lift the restriction on rural and free-standing cancer hospitals’ access to 340B pricing on orphan drugs.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)